AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Nouveau Life Pharmaceuticals, Inc.

$0.00 +$0.00 (+100.00%)
OTC · 30 Oct 2026 20:00 UTC
Previous Close
$0.00
Day Range
$0.00 - $0.00
Year Range
$0.00$0.00
Market Cap
90K
AVG Volume
419.56K
Trailing/Forward PE
-0.01/-
PEG ratio
-0
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Net Income (USD) · TTM
-600K-400K-200K006 Q206 Q306 Q407 Q107 Q207 Q307 Q408 Q108 Q208 Q3
NOUV Net Income (USD) by quarter, trailing twelve months
PeriodNet Income (USD)
08 Q3-503.31K
08 Q2-446.66K
08 Q1-409.6K
07 Q4-356.23K
07 Q3-295.48K
07 Q2-281.49K
07 Q1-269.89K
06 Q4-256.82K
06 Q3-326.93K
06 Q2-393.77K
Operating Income (USD) · TTM
0200K400K600K06 Q206 Q306 Q407 Q107 Q207 Q307 Q408 Q108 Q208 Q3
NOUV Operating Income (USD) by quarter, trailing twelve months
PeriodOperating Income (USD)
08 Q3503.31K
08 Q2446.66K
08 Q1409.6K
07 Q4356.23K
07 Q3357.54K
07 Q2323.89K
07 Q1312.3K
06 Q4309.72K
06 Q3298.32K
06 Q2365.31K
EBITDA · TTM
Cash Flows · TTM
EPS · TTM
Expenses · TTM
Cash & Debt · TTM
Debt ratios · TTM
Margins · TTM
Return on Capital · TTM
Shares Outstanding · TTM
Dividends (USD) · TTM
Employee Count
Book Value Per Share · TTM
Total Assets · TTM
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book
Nouveau Life Pharmaceuticals, Inc.
NOUV
Stockpicker

Video analysis: NOUV

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: NOUV

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.